The pattern of bilirubin response to phototherapy was studied using lamps with an emission spectrum closely similar to the bilirubin absorption spectrum. A dose-response relationship was demonstrated, with increased intensity of phototherapy resulting in greater response; however, the rate of bilirubin decline progressively decreased with increasing radiance till a 'saturation' point was reached, beyond which no further response occurred with further increase in radiance, suggesting a curvilinear relationship of the nature of an asymptotic regression. At the 'saturation' point, a 24-h decline of about 50% was achieved.
The pattern of bilirubin response to phototherapy has not been clearly defined before. Although the nature of the dose-response relationship of phototherapy for neonatal hyperbilirubinaemia has been documented (9) , the pattern of bilirubin decline in neonates in response to continuous phototherapy pver extended periods has never been reported as far as can be ascertained. Furthermore, it has been suggested that the spectral emission curves of the lamps employed in the dose-response study were not altogether suitable for such an investigation (1) .
With the availability of lamps with a spectral emission curve closely approximating to the bilirubin absorption curve, it was thought that an investigation into the pattern of the bilirubin decline in response to increasing light radiance, as well as extended periods of phototherapy would be worthwhile. The following paper is an attempt at such a study.
MATERIALS AND METHODS
Two studies were performed: the first investigated the doseresponse relationship, and the second the bilirubin decline over an extended period of phototherapy. Informed consent was obtained.
In the first study, fullterm 'healthy' infants with nonhaemolytic hyperbilirubinaemia as previously defined (10) were divided into nine matched groups based on the following parameters: birth weight, gestational and postnatal age and haemoglobin (Hb) and bilirubin levels at onset of phototherapy. Phototherapy was provided by stationary frames to which were attached Philips TL20W/52 lamps with a spectral emission curve closely similar to the bilirubin absorption curve (Fig. 1) . A system of switches was employed to provide different light intensities. Each group of infants was exposed to phototherapy of different radiance, the phototherapy commencing in the morning. The light measurements were made by the l i A photometer/radiometer (United Detector Technology Inc., USA) as described previously (10) .
Each infant was exposed unclothed (except for eye pads) to continuous phototherapy interrupted only for feeding, nursing and 6-h capillary blood sampling for bilirubin determination. Feeds were increased during phototherapy to offset the tendency to greater fluid loss (5) . During blood sampling the lights were switched off, the blood collected in capillary tubes, placed in labeled red coloured straws, and kept in a light tight box until the moment of bilirubin determination. Phototherapy was only discontinued when the bilirubin level had declined below 1 1 mg/dl, the minimum period of exposure being 48 h. After cessation of phototherapy, daily bilirubin levels were monitored until a static or declining trend was observed, the minimal period being 2 days. Total bilirubin was determined under uniform conditions by an A 0 Bilirubinometer (American Optical Corp., USA), the results correlating well with those by the method of Malloy and Evelyn (3). Direct acting bilirubin was determined in random samples by the method of Malloy and Evelyn (3).
The second study was started only after the first study had been evaluated. Two intensities of light were selected for this study, one for moderate response, and the other for maximal response, hereafter referred to as moderate and maximal intensity phototherapy respectively; the light radiance corresponded to those of groups 5 and 7 respectively of the first study. The decision to select a radiance corresponding to group 5 for moderate intensity phototherapy was based on the desire for a light radiance that, though obviously less than that of maximal intensity phototherapy, was still able to elicit a pattern of bilirubin response (decline) within an acceptable period of exposure, a situation probably not possible with a lesser radiance.
Fullterm 'healthy' infants with nonhaemolytic hyperbilirubinaemia were divided into two groups, the first being exposed to moderate intensity phototherapy for 4 continuous days, and the second to maximal intensity phototherapy for 3 continuous days. The infants were nursed in the same manner as in the first study, with capillary blood sampling at 6-h intervals. To offset the effect of diurnal variation of bilirubin levels on the 6-h evaluation of mean bilirubin values, each infant within each group was started on phototherapy at a different time during daylight hours.
The results were subjected to statistical evaluation.
RESULTS
All the infants in both studies were well before, during and after phototherapy. Increased ventilation from an overhead ceiling fan was required to maintain normothermia in those exposed to high intensity phototherapy from multiple lamps. As previously observed (9, lo), bilirubin levels varied with the time of the day. On no occasion did the direct acting bilirubin exceed 1 mg/dl in the random samples determined.
In the first study (Table I) , the only reliable criterion for assessing the efficacy of phototherapy was the 24-h decline in bilirubin values during phototherapy; the 24-h decline was expressed as a proportion of the initial bilirubin value. A doseresponse relationship was observed (Table 2 ) with the rate of decline becoming progressively less with increased radiance until was later re~orted both in the neonate (9) and the Gunn rat (2).
a 'saturation' point was reached, beyond which no further decline for the 440-480 nanometer (nm) range, 50.26 pW/cmL for the occurred with further increase in radiance (Fig. 2) , suggesting an 425-475 nm range, and 54.7 1 pW/cm2 for the 400-480 nm range. asymptotic regression; at 'saturation' point a decline of about 50% Two infants in Group 1 experienced a rise in 24-h bilirubin levels was observed. A semi-logarithmic presentation of the results dem-and had to be removed from the study for more effective treatonstrated a linear relationship (Fig. 3) ; by extrapolation the dosage ment. The number of infants with 24-h bilirubin values below 11 of light for minimal effectiveness was 3 1.85 pWatts/cm2 (pW/cm2) mg/dl were greater in the groups exposed to more intense phototherapy. The second 24-h decline was less marked than the first nm.
The preseni study confirms the asympidtic nature of the ddseresponse relationship of a previous study (9) by the same author. 37% in the earlier study (9) . This increased efficacy was obviously 24-h decline; however, no valid comparisons could be made among the groups as the mean bilirubin values of the groups at the start of this second period were no longer comparable. Postphototherapy rebound in bilirubin levels was generally mild in all nine groups. In the second study (Table 3) , the infants commenced phototherapy at different times within each study group; thus, virtually with declining values; at about 5 mg/dl very little further decline with continued phototherapy was observed in both groups of infants (Fig. 4 ). An exponential regression was suggested. Semilogarithmic presentation of the results demonstrated a linear relationship (Fig. 5) . The 24-h bilirubin declines were evaluated at 6-h intervals, each decline being expressed as a proportion of the bilirubin value at the commencement of the 24-h period. A linear relationship was observed between the 24-h declines and the bilirubin values at the start of the 24-h periods (Fig. 6 ) especially in the group subjected to high intensity phototherapy, demonstrating that the rate of decline was directly proportional to the bilirubin value at the start of the 24-h period. Only a mild postphototherapy rebound was observed. The end of phototherapy, Hb and PCV values were not significantly different between the two groups (Fig. 3) . the result of the lamps used in the present study having a more effective spectral emission curve. In contrast to the failure to find a limitation effect of phototherapy at even very high radiances by Wiese and Ballowitz (13) , the present study demonstrated a 'saturation' point, the radiance of which in the relevant waveband was about the same as that of a previous report (7) . This 'saturation' point radiance and also the radiance for minimal effectiveness were much higher than those (Fig. 7) reported by the author earlier (9) , a surprising observation. These differences were too great to be attributed to measurement errors. The measurements made, however, involved narrow wavebands, which though of major importance with regard to phototherapeutic effect, did not include other wavelengths which may be of some effect in phototherapy though less so (6). This is especially relevant in the extrapolated minimal effective dose. In the previous study, broad spectrum daylight lamps were used for the lower radiance levels and narrow spectrum blue/violet lamps for the higher radiance levels. This would also explain the convergence of the regression curves on semi-logarithmic presentation. The almost parallel regression curves in the present report was the result of the use of the same type of lamp throughout the whole study.
In the second study, the effect of diurnal variation on bilirubin values was virtually eliminated by commencing phototherapy at different times for each infant within each study group. An exponential regression was suggested. Such an observation had previously been made in Gunn rats (1 1, 12) . In these studies, a lesser maximal response for lesser radiance (as calculated from the cumulative dosage of continuous and intermittent phototherapy regimes) was observed even for prolonged periods of photother- apy. Such a response was not observed in the present study even 20 r though the dosage of moderate intensity phototherapy was only about two-thirds of that of maximal intensity phototherapy; an equally low bilirubin value was obtained but after a longer dura- Radiance ( p W l sq c r n ) -log scale Fig. 7 . A semi-logarithmic presentation of the dose-response relationship of a previous study (5) redrawn with the radiance values in the 440-480 nm waveband added.
The ideal light intensity for phototherapy has yet to be defined. As demonstrated in this paper, differences in light intensity could result in different responses in bilirubin decline. Certainly in cases of severe hyperbilirubinaemia or rapidly progressive jaundice, where need for rapid control of the condition is obvious, it would be advisable to use high intensity phototherapy. The duration of phototherapy and the bilirubin levels at which cessation of treatment is indicated have also as yet not been clearly defined. The present study demonstrates that further phototherapy would be of minimal efficacy where bilirubin levels have declined to about 5 mg/dl. Postphototherapy rebound was also mild in jaundice due to nonhaemolytic causes.
